AlphAIalphai — Financial news for AI agents
investing.comAUG 134 min read$LGN

Earnings call transcript: Legence misses Q2 2026 EPS as stock falls 6.3%

Legence (LGN) reported Q2 2026 revenue of $1.262B, up from $599M a year earlier, and adjusted EBITDA of $155M. Adjusted EPS was -$0.37 versus a $0.21 consensus estimate. The stock fell 6.3% premarket to $64.35. Legence raised full-year 2026 revenue guidance to $4.7B-$4.8B and EBITDA to $565M-$585M.

Original reporting
investing.com
Published Aug 13, 2026, 3:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$LGN
Bearish
medium confidence
Mentioned
$LGN
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$LGNBearishMed
01

Why it matters

The market reaction focuses on the EPS miss and margin pressure, while management’s raised 2026 revenue and EBITDA guidance provides a counterweight for forward expectations.

02

Market read

Traders get a fresh earnings-and-guidance datapoint plus a clear margin-mix explanation, which can drive near-term positioning around execution and EPS bridge items.

03

What to watch

The article suggests non-operating and acquisition-related effects weighed on EPS, so traders should separate the EPS bridge from the operating trend and watch whether gross margin stabilizes as mix normalizes.

Relevance 8/10Novelty 7/10Timing: pre-market today after Q2 2026 earnings release

Background

Legence reported strong Q2 operating growth and record backlog, but the headline adjusted EPS missed consensus and gross margin declined on mix.

Company-level read

Ticker impact

$LGNBearishMedium confidence
Context

Legence missed Q2 2026 adjusted EPS (-$0.37 vs +$0.21) and shares fell 6.3% premarket despite raised full-year revenue guidance.

Expected impact

Near-term downside risk remains tied to margin mix and EPS bridge items, but raised 2026 revenue and EBITDA guidance may limit further deterioration if execution holds.

Evidence & confidence

The article cites a large EPS miss versus consensus, adjusted gross margin down to 18.5% from 21.8%, and management attributing margin decline to mix shift toward installation and maintenance.

Market effects

Sector

Highlights margin sensitivity in building-systems contractors when revenue mix shifts toward installation and maintenance.

Regional

No specific regional macro impact beyond demand commentary (data centers, semiconductors).

Global

Limited global spillover; primarily company-specific read-through on contractor margin dynamics.

Counterpoint

What could challenge this read

Investors may be over-weighting the adjusted EPS miss if the underlying operating momentum (revenue, backlog, EBITDA growth) and raised guidance prove durable.

Key entities

  • company
    Legence

    Building-systems contractor reporting Q2 2026 results, EPS miss, and raised full-year guidance.

  • executive
    Jeff Sprau

    CEO cited robust demand and organic growth/backlog strength.

  • executive
    Stephen Butz

    CFO attributed gross margin decline primarily to revenue mix shift toward installation and maintenance.

Read at source← All news

Also covered by

1 outlet

Related articles

AUG 14
$LGNHighAI 9/10

Legence (LGN) Q2 2026 Earnings Call Transcript

Legence (LGN) reported Q2 2026 revenue of $1.3B, up 110.7% year over year, driven by the Bowers Group acquisition and data center demand. Adjusted EBITDA rose to $154.6M, margin 12.2%. Backlog and awards were $5.7B. The company raised Q3 and full-year 2026 guidance, including FY revenue $4.7B-$4.8B and adjusted EBITDA $565M-$585M.

fool.com6 min
AUG 13
MedAI 8/10

Legence Q2 2026 slides: record revenue, backlog despite margin pressure

Legence Corp. reported Q2 2026 results on Aug. 13, citing record revenue and backlog growth tied to data center and mission-critical building systems demand. Revenue rose to $1.262B (+111% YoY) and backlog to $5.67B (+105%). Adjusted EPS was -$0.37 vs +$0.21 expected. Shares fell over 7% to $63.68; full-year guidance was raised to $4.7B-$4.8B revenue.

investing.com7 min
AUG 13
$LGNMedAI 8/10

Legence revenue rises 110.7% to $1.26 billion

Legence (NASDAQ:LGN) reported Q2 2026 revenue of $1.26 billion, up 110.7% year over year, and Adjusted EBITDA of $154.6 million. The company posted a net loss of $27.8 million and ended with $292 million cash and $1.03 billion debt. It raised FY2026 revenue guidance to $4.7–$4.8 billion and Adjusted EBITDA to $565–$585 million.

grafa.com4 min
AUG 13
$LGNMed

Legence Q3 Results: Sales Guidance $1.225B

Legence (NASDAQ: LGN) guided Q3 sales to $1.225B to $1.275B, above the $1.080B analyst consensus. The low end is about $145M higher, implying roughly 13% above street expectations. No other financial metrics were provided in the source.

scanx.trade2 min
AUG 13
Med

Legence Corp. Revises Earnings Guidance for Full Year 2026

Legence Corp. revised its full-year 2026 earnings guidance, raising expected total revenues to $4.7 billion to $4.8 billion from a prior range of $4.1 billion to $4.3 billion. The company provides engineering, installation and maintenance services for mission-critical building systems, operating in Engineering & Consulting and Installation & Maintenance segments.

marketscreener.com2 min